MDFA and the eye health community is saddened to learn of the passing of Mr. Richard Grills
The 2022 Supporter Survey results are in.
Specsavers and Macular Disease Foundation Australia have begun a strategic scoping partnership.
Researchers confirm the AREDS2 formulation is safe for use over a decade.
Faricimab has taken one step closer towards clinics in Australia.
Quality CPD education from leading macular disease experts.
MDFA strives to address challenges for people receiving intravitreal injections.
MDFA teams up with Healthily to deliver education via GPs.
MDFA offers Peer to Peer phone calls as well as peer support groups, both face-to-face and online.